Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
RAFLF
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through Healthcare Services, Hospital Services, and Investment Holdings segments. Its flagship hospital is the Raffles Hospital, a tertiary care hospital that offers cancer, children and women care, Chinese medicine, counselling, dental, dialysis, diabetes and endocrinology, ear, nose, throat, eye, fertility, heart, internal medicine, neuroscience, pain management, rehabilitation, orthopedic, skin and aesthetics, surgery, nuclear medicine, and urology services. The company also offers emergency services, family medicine services, health screening, and various multi-disciplinary specialist clinic services. In addition, it trades in pharmaceutical and nutraceutical products, and diagnostic equipment; provides advisory and consultancy services, and develops IT solutions; and engages in research and experimental development on biotechnology, and life and medical science. Raffles Medical Group Ltd was founded in 1976 and is based in Singapore. Raffles Medical Group Ltd operates as a subsidiary of Raffles Medical Holdings Pte. Ltd.
OTC
Relative Strenght
Volume Buzz
3348%
Earning Acce
No
Dist 52w H.
0%Earnings Growth
YoY
Current
Estimates
Q3.22
+89%
0.02
vs 0.01
Q4.22
-6%
0.02
vs 0.02
Q1.23
+0%
0.02
vs 0.02
Q2.23
-50%
0.02
vs 0.03
Q3.23
-64%
0.01
vs 0.02
Q4.23
-64%
0.01
vs 0.02
Q1.24
-49%
0.01
vs 0.02
Q2.24
-49%
0.01
vs 0.02
Q3.24
-9%
0.01
vs 0.01
Q4.24
-11%
0.01
vs 0.01
Sales Growth
YoY
Current
Estimates
Q3.22
+9%
207.6M vs 190.7M
Q4.22
-45%
207.6M vs 380M
Q1.23
-10%
185.4M vs 204.9M
Q2.23
-52%
185.4M vs 382.3M
Q3.23
-19%
168.6M vs 207.6M
Q4.23
-19%
168.6M vs 207.6M
Q1.24
-1%
182.8M vs 185.4M
Q2.24
-1%
182.8M vs 185.4M
Q3.24
-42%
97.7M vs 168.6M
Q4.24
-43%
96.9M vs 168.6M
Return on Equity
QoQ
Q4.22
+4%
0.04
vs 0.04
Q1.23
+3%
0.03
vs 0.04
Q2.23
+3%
0.03
vs 0.03
Q3.23
+1%
0.01
vs 0.03
Q4.23
+1%
0.01
vs 0.01
Q1.24
+2%
0.02
vs 0.01
Q2.24
+2%
0.02
vs 0.02
Q4.24
NA
NA
vs 0.02
Institutionnal Ownership
Relative Strength
RAFLF
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics
Forecast
230%2025-Revenue
258%2025-EPS
350%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available